These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 34362853)
1. Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Kuwabara S J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):32-40. PubMed ID: 34362853 [TBL] [Abstract][Full Text] [Related]
2. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Cortese R; Battaglini M; Prados F; Gentile G; Luchetti L; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Apostolos Pereira SL; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira À; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Pröbstel AK; Granziera C; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Barkhof F; Ciccarelli O; De Stefano N; Ann Neurol; 2024 Aug; 96(2):276-288. PubMed ID: 38780377 [TBL] [Abstract][Full Text] [Related]
3. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869 [TBL] [Abstract][Full Text] [Related]
4. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder. Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547 [TBL] [Abstract][Full Text] [Related]
5. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis. Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104 [TBL] [Abstract][Full Text] [Related]
6. Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls. Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Hirano Y; ; Kuwabara S Sci Rep; 2023 Aug; 13(1):12631. PubMed ID: 37537208 [TBL] [Abstract][Full Text] [Related]
7. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody. Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704 [TBL] [Abstract][Full Text] [Related]
8. Early and extensive spinal white matter involvement in neuromyelitis optica. Hayashida S; Masaki K; Yonekawa T; Suzuki SO; Hiwatashi A; Matsushita T; Watanabe M; Yamasaki R; Suenaga T; Iwaki T; Murai H; Kira JI Brain Pathol; 2017 May; 27(3):249-265. PubMed ID: 27082714 [TBL] [Abstract][Full Text] [Related]
9. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS. Duan Y; Zhuo Z; Li H; Tian DC; Li Y; Yang L; Gao C; Zhang T; Zhang X; Shi FD; Barkhof F; Liu Y J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):709-716. PubMed ID: 33687975 [TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach. Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657 [TBL] [Abstract][Full Text] [Related]
11. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis. Messina S; Mariano R; Geraldes R; Kim SH; Satukijcha C; Vecchio D; Chua YY; Taylor J; George N; Cavey A; Diaz AR; Reeve S; Everett R; De Luca G; Leite MI; Kim HJ; Palace J Mult Scler Relat Disord; 2021 Apr; 49():102773. PubMed ID: 33540279 [TBL] [Abstract][Full Text] [Related]
12. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Messina S; Mariano R; Roca-Fernandez A; Cavey A; Jurynczyk M; Leite MI; Calabrese M; Jenkinson M; Palace J Mult Scler; 2022 Feb; 28(2):217-227. PubMed ID: 34048323 [TBL] [Abstract][Full Text] [Related]
13. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients. Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369 [TBL] [Abstract][Full Text] [Related]
14. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235 [TBL] [Abstract][Full Text] [Related]
16. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder. Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648 [TBL] [Abstract][Full Text] [Related]
17. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients. Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748 [TBL] [Abstract][Full Text] [Related]
18. The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study. Barć K; Gospodarczyk-Szot K; Nojszewska M; Podlecka-Piętowska A; Zakrzewska-Pniewska B Mult Scler Relat Disord; 2020 Sep; 44():102265. PubMed ID: 32575026 [TBL] [Abstract][Full Text] [Related]
19. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders]. Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. Masuda H; Hirano S; Takahashi N; Hatsugano E; Uzawa A; Uchida T; Ohtani R; Kuwabara S; Mori M PLoS One; 2017; 12(8):e0184012. PubMed ID: 28846745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]